000 01585 a2200457 4500
005 20250513150831.0
264 0 _c19980908
008 199809s 0 0 eng d
022 _a0006-291X
024 7 _a10.1006/bbrc.1998.9007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLaezza, C
245 0 0 _aControl of Rab5 and Rab7 expression by the isoprenoid pathway.
_h[electronic resource]
260 _bBiochemical and biophysical research communications
_cJul 1998
300 _a469-72 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCell Line
650 0 4 _aCycloheximide
_xpharmacology
650 0 4 _aGTP Phosphohydrolases
_xmetabolism
650 0 4 _aGTP-Binding Proteins
_xbiosynthesis
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aKinetics
650 0 4 _aLovastatin
_xpharmacology
650 0 4 _aMevalonic Acid
_xmetabolism
650 0 4 _aProtein Prenylation
650 0 4 _aRNA, Messenger
_xbiosynthesis
650 0 4 _aRats
650 0 4 _aThyroid Gland
650 0 4 _aTime Factors
650 0 4 _aTranscription, Genetic
_xdrug effects
650 0 4 _arab GTP-Binding Proteins
650 0 4 _arab5 GTP-Binding Proteins
650 0 4 _arab7 GTP-Binding Proteins
700 1 _aBucci, C
700 1 _aSantillo, M
700 1 _aBruni, C B
700 1 _aBifulco, M
773 0 _tBiochemical and biophysical research communications
_gvol. 248
_gno. 3
_gp. 469-72
856 4 0 _uhttps://doi.org/10.1006/bbrc.1998.9007
_zAvailable from publisher's website
999 _c9669554
_d9669554